Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism

Neurosurgery

Volumn 61, Issue 4, 2007, Pages 788-792

  Weigel, Ralf ^a   Hohenstein, Axel ^a   Schlickum, Linda ^a   Weiss, Christel ^a   Schilling, Lothar ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aged; Angiotensin converting enzyme inhibitors; Chronic subdural hematoma; Humans; Recurrence; Vascular endothelial growth factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASCULOTROPIN;

ADULT; AGE DISTRIBUTION; AGED; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN SURGERY; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERTENSION; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SEX DIFFERENCE; SUBDURAL HEMATOMA; VENOUS BLOOD;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS;

EID: 35949004416     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000298907.56012.E8     Document Type: Article

References (19)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994.
2. Anlauf M: ACE inhibitors and angiotensin receptor anatagonists [in German], in Schwabe U, Paffrath D (eds): Drug Prescription Report 2005. Current Data, Costs, Trends, and Comments [in German]. Berlin, Springer, 2006, pp 247-276.
3. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH: Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID study group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351:28-31, 1998.
4. Friede RL, Schachenmayr W: The origin of subdural neomembranes. II. Fine structural of neomembranes. Am J Pathol 92:69-84, 1978.
5. Gilbert RE, Kelly DJ, Cox AJ, Wilkinson-Berka JL, Rumble JR, Osicka T, Panagiotopoulos S, Lee V, Hendrich EC, Jerums G, Cooper ME: Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia 43:1360-1367, 2000.
6. Hohenstein A, Erber R, Schilling L, Weigel R: Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. J Neurotrauma 22:518-528, 2005.
7. Ito H, Yamamoto S, Saito K, Ikeda K, Hisada K: Quantitative estimation of hemorrhage in chronic subdural hematoma using the 51Cr erythrocyte labeling method. J Neurosurg 66:862-864, 1987.
8. Markwalder TM, Steinsiepe KF, Rohner M, Reichenbach W, Markwalder H: The course of chronic subdural hematomas after burr-hole craniostomy and closed-system drainage. J Neurosurg 55:390-396, 1981.
9. Merchan JR, Chan B, Kale S, Schnipper LE, Sukhatme VP: In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. J Natl Cancer Inst 95:388-399, 2003.
10. Mori K, Mitsuoka H, Cho K, Tajima A, Maeda M: Rate constant of gadolinium (Gd)-DTPA transfer into chronic subdural hematomas. Neurol Res 18:126-134, 1996.
11. Nakamura S, Tsubokawa T: Extraction of angiogenesis factor from chronic subdural haematomas. Significance in capsule formation and haematoma growth. Brain Inj 3:129-136, 1989.
12. Sato S, Suzuki J: Ultrastructural observations of the capsule of chronic subdural hematoma in various clinical stages. J Neurosurg 43:569-578, 1975.
13. Suzuki K, Takano S, Nose T, Doi M, Ohashi N: Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma 46:532-533, 1999.
14. Vaquero J, Zurita M, Cincu R: Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien) 144:343-347, 2002.
15. Vogt B, Frey FJ: Inhibition of angiogenesis in Kaposi's sarcoma by captopril. Lancet 349:1148, 1997.
16. Weigel R, Krauss JK, Schmiedek P: Concepts of neurosurgical management of chronic subdural haematoma: Historical perspectives. Br J Neurosurg 18:8-18, 2004.
17. Weigel R, Schilling L, Schmiedek P: Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): Evidence for an angiogenic disease. Acta Neurochir (Wien) 143:811-819, 2001.
18. Weigel R, Schmiedek P, Krauss JK: Outcome of contemporary surgery for chronic subdural haematoma: Evidence based review. J Neurol Neurosurg Psychiatry 74:937-943, 2003.
19. Yamashima T, Yamamoto S, Friede RL: The role of endothelial gap junctions in the enlargement of chronic subdural hematomas. J Neurosurg 59:298-303, 1983.